EMEA-002104-PIP01-16

Key facts

Active substance
  • Olmesartan medoxomil
  • hydrochlorothiazide
  • Amlodipine besilate
Therapeutic area
Cardiovascular diseases
Decision number
P/0177/2017
PIP number
EMEA-002104-PIP01-16
Pharmaceutical form(s)
Tablet
Condition(s) / indication(s)
Treatment of hypertension
Route(s) of administration
Oral use
Contact for public enquiries
Accord Healthcare S.L.U.

E-mail: regulatory_EU@accord-healthcare.com
Tel. +34 933010064

Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

How useful was this page?

Add your rating